• Viral Control of RIPK3 Degradation Modulates Necroptosis and

  2026-05-28

  Liu et al. uncover a viral mechanism targeting the necroptosis adaptor RIPK3 for proteasomal degradation, revealing how orthopoxviruses modulate host cell death and inflammatory responses. This work advances understanding of host-pathogen interactions and provides new context for studying ubiquitin-mediated protein regulation in infection biology.

• Technical Guide: HyperPFU™ High-Fidelity DNA Polymerase in P

  2026-05-27

  HyperPFU™ high-fidelity DNA polymerase addresses the technical challenges of amplifying long, GC-rich, or otherwise difficult DNA templates where standard Taq or non-proofreading enzymes often fail due to low fidelity and poor processivity. This enzyme is optimal for workflows requiring highly accurate, blunt-ended PCR products, but it is not suitable for applications needing 3'-A overhangs or sticky ends.

• Gamma-linolenic Acid (GLA): Reliable Solutions for Cell Assa

  2026-05-27

  This article delivers evidence-based guidance for using Gamma-linolenic acid (GLA, SKU C5518) in cell viability, proliferation, and cytotoxicity assays. Drawing from recent literature and validated product data, it addresses real-world workflow challenges and demonstrates how GLA optimizes anti-inflammatory research and apoptosis assays. Researchers will find scenario-driven insights for robust, reproducible results using APExBIO's high-purity GLA.

• Moxidectin Synergizes with Polyenes Against Oral Candida alb

  2026-05-26

  This study reveals that moxidectin, a macrocyclic lactone anthelmintic, enhances ergosterol biosynthesis in Candida albicans, thereby potentiating the efficacy of polyene antifungals against oral candidiasis. These findings provide mechanistic insight into a novel antifungal strategy with potential translational application in drug-resistant fungal infections.

• Pharmacokinetic Variability of CSBTA in MASH: Insights for D

  2026-05-26

  This study provides a comprehensive analysis of how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. The findings underscore the importance of disease state, transporter, and enzyme expression in optimizing therapeutic regimens for chronic liver diseases.

• URB597 (KDS-4103): Precision FAAH Inhibition in Pain Researc

  2026-05-25

  URB597 (KDS-4103) enables rapid, selective FAAH inhibition, making it indispensable for dissecting endocannabinoid signaling in neuroplasticity and inflammatory pain models. This guide translates breakthrough findings into actionable bench workflows, troubleshooting tactics, and advanced applications—anchored by the latest reference study and APExBIO’s best-in-class reagent quality.

• Paclitaxel (Taxol): Advanced Workflows for Cancer Research

  2026-05-25

  Paclitaxel (Taxol) stands out as a versatile microtubule polymer stabilizer, enabling precise cell cycle manipulation in cancer models. This guide provides actionable protocols, experimental enhancements, and troubleshooting strategies—unlocking its full potential across breast, ovarian, and advanced PI3K/AKT/mTOR pathway studies.

• Morin in Translational Research: Protocols, Probes, and Pitf

  2026-05-24

  Morin, a high-purity flavonoid from APExBIO, enables robust workflows for disease modeling and fluorescent ion detection. This article distills evidence-backed protocols, troubleshooting strategies, and novel assay approaches to maximize reproducibility and interpretability in diabetes, neuroprotection, and cell-based research.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor: Applied Workflows

  2026-05-23

  Digoxin offers unique dual-utility in cardiovascular and antiviral research, enabling precise modulation of cardiac contractility and inhibition of chikungunya virus infection in select human cell models. Rigorous quality control and cell-type specificity make Digoxin from APExBIO a reliable choice for both bench-scale assays and advanced translational studies.

• Recombinant Human Growth Hormone: IGFBP2-THBS1 Axis in Assay

  2026-05-22

  Explore the pivotal role of recombinant human growth hormone in research, with a focus on the IGFBP2-THBS1 axis and its impact on cell proliferation assays. This article delivers advanced assay insights and protocols for scientists pursuing breakthroughs in somatotropin signaling.

• Apicidin: Precision HDAC Inhibition and Assay Design Insight

  2026-05-22

  Explore Apicidin as a selective histone deacetylase inhibitor—its molecular mechanisms, advanced research protocols, and unique risk-benefit profile. Gain a deeper understanding for designing robust, reproducible assays using this potent anti-proliferative agent.

• Low Molecular Weight Fucoidan Inhibits Ferroptosis in Pulmon

  2026-05-21

  This study demonstrates that low molecular weight fucoidan (LMWF), derived from Laminaria japonica, significantly inhibits ferroptosis and attenuates pulmonary fibrosis in a mouse model. The findings clarify the mechanistic link between LMWF, mitochondrial preservation, and the suppression of iron- and ROS-mediated cell death, advancing the understanding of novel therapeutic strategies for fibrotic lung diseases.

• Deferoxamine Mesylate: Precision Iron Chelation for Ferropto

  2026-05-21

  Explore how Deferoxamine mesylate, a leading iron-chelating agent, enables next-generation ferroptosis and oxidative stress studies through precise modulation of iron metabolism. Uncover unique insights into NRF2 pathway interactions and advanced assay design.

• Diclofenac: Non-Selective COX Inhibitor in Intestinal Organo

  2026-05-20

  Unlock the power of Diclofenac, a high-purity non-selective COX inhibitor, to model human inflammation and drug metabolism using hiPSC-derived intestinal organoids. This guide translates cutting-edge protocols into actionable steps, highlighting troubleshooting strategies and APExBIO’s reliable product performance for advanced pharmacokinetic and pain signaling research.

• BI 2536: PLK1 Inhibitor Workflows for Cancer Research Excell

  2026-05-20

  BI 2536 enables precise cell cycle and apoptosis studies, setting the gold standard for PLK1 inhibitor use in both in vitro and in vivo cancer models. This guide details robust workflows, troubleshooting, and experimental insights to maximize the impact of BI 2536 in translational oncology.

406 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page